Brief: Liminal Biosciences Receives FDA Approval For Its U.S.-Based Plasma Collection Center
12/01/2021 14:21
Jan 12 (Reuters) - Liminal BioSciences Inc LMNL.O :
* LIMINAL BIOSCIENCES RECEIVES FDA APPROVAL FOR ITS
U.S.-BASED
PLASMA COLLECTION CENTER
Source text for Eikon: ID:nCNW6G0Nfa
Further company coverage: LMNL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Liminal BioSciences
See all newsBrief: Liminal Biosciences Announces Completion Of The Plan Of Arrangement With Structured Alpha Lp
Brief: Liminal Biosciences Files Amended Schedule 13E-3 And Supplement To Management Information Circular
Brief: Liminal Biosciences Obtains Interim Order For Proposed Arrangement With Structured Alpha Lp
U.S. STOCKS ON THE MOVE-Liminal Biosciences, Tesla, Quad/Graphics
U.S. STOCKS ON THE MOVE-T2 Biosystems, GoodRx Holdings, ShiftPixy